MARA Holdings
MARA
MicroStrategy
MSTR
Tesla
TSLA
Coinbase
COIN
Amazon
AMZN
US Stock MarketDetailed Quotes
CTOR Citius Oncology
- 1.300
- +0.110+9.24%
Close Jan 3 16:00 ET
93.02MMarket Cap-4.39P/E (TTM)
1.347High1.168Low238.53KVolume1.220Open1.190Pre Close297.20KTurnover4.34%Turnover RatioLossP/E (Static)71.55MShares49.00052wk High2.02P/B7.15MFloat Cap0.85052wk Low--Dividend TTM5.50MShs Float49.000Historical High--Div YieldTTM15.05%Amplitude0.850Historical Low1.245Avg Price1Lot Size
Citius Oncology Key Stats
Quarterly+Annual
YOY
| (FY)Sep 30, 2024 | (FY)Sep 30, 2023 | (FY)Sep 30, 2022 | |
|---|---|---|---|
| Assets | |||
| Current assets | |||
| Cash, cash equivalents and short term investments | --112 | --0 | --0 |
| -Cash and cash equivalents | --112 | --0 | --0 |
| Inventory | --8.27M | --0 | ---- |
| Prepaid assets | -65.09%2.7M | 187.52%7.73M | --2.69M |
| Total current assets | 41.81%10.97M | 187.52%7.73M | --2.69M |
| Non current assets | |||
| Goodwill and other intangible assets | 83.50%73.4M | 0.00%40M | --40M |
| -Other intangible assets | 83.50%73.4M | 0.00%40M | --40M |
| Total non current assets | 83.50%73.4M | 0.00%40M | --40M |
| Total assets | 76.74%84.37M | 11.82%47.73M | --42.69M |
| Liabilities | |||
| Current liabilities | |||
| Payables | 57.30%32.7M | 334.36%20.79M | --4.79M |
| -accounts payable | 187.94%3.71M | 1,296.42%1.29M | --92.31K |
| -Due to related parties current | -96.98%588.81K | 315.44%19.5M | --4.69M |
| -Other payable | --28.4M | ---- | ---- |
| Current accrued expenses | --0 | -75.58%259.07K | --1.06M |
| Other current liabilities | --1 | ---- | ---- |
| Current liabilities | 55.37%32.7M | 259.98%21.05M | --5.85M |
| Non current liabilities | |||
| Long term debt and capital lease obligation | --3.8M | ---- | ---- |
| -Long term debt | --3.8M | ---- | ---- |
| Non current deferred liabilities | 50.00%1.73M | 100.00%1.15M | --576K |
| Other non current liabilities | ---1 | ---- | ---- |
| Total non current liabilities | 379.87%5.53M | 100.00%1.15M | --576K |
| Total liabilities | 72.21%38.23M | 245.63%22.2M | --6.42M |
| Shareholders'equity | |||
| Share capital | 6.00%7.16K | 0.00%6.75K | --6.75K |
| -common stock | 6.00%7.16K | 0.00%6.75K | --6.75K |
| -Preferred stock | --0 | --0 | --0 |
| Retained earnings | -116.65%-39.28M | -233.72%-18.13M | ---5.43M |
| Paid-in capital | 95.63%85.41M | 4.71%43.66M | --41.69M |
| Total stockholders'equity | 80.69%46.14M | -29.59%25.54M | --36.27M |
| Total equity | 80.69%46.14M | -29.59%25.54M | --36.27M |
| Currency Unit | USD | USD | USD |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- |
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.